首页|Data on Artificial Intelligence Reported by Josef Ruschoff and Colleagues [Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institu tional Study on Comparison of Manual and Artificial Intelligence Measurement Mod el ...]
Data on Artificial Intelligence Reported by Josef Ruschoff and Colleagues [Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institu tional Study on Comparison of Manual and Artificial Intelligence Measurement Mod el ...]
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Artificial Intelligenc e is the subject of a report. According tonews reporting originating from Kasse l, Germany, by NewsRx correspondents, research stated, “Assessingprogrammed dea th ligand 1 (PD-L1) expression on tumor cells (TCs) using Food and Drug Administ rationapproved,validated immunoassays can guide the use of immune checkpoint i nhibitor (ICI) therapy in cancertreatment. However, substantial interobserver v ariability has been reported using these immunoassays.”
KasselGermanyEuropeArtificial Inte lligenceCancerCarcinomasEmerging TechnologiesHealth and MedicineImmuno assayMachine LearningOncologyPathologyUrothelial Cancer
NETL
NSTL
